 |
 |
|
|
|
| Riluzole |
 |
| 6-(trifluoromethoxy)-2-benzothiazolamine |
 |
| 1744-22-5 |
 |
Riluzole is a drug used to treat amyotrophic lateral sclerosis. It delays the onset of ventilator-dependence or tracheostomy in selected patients and may increase survival by approximately two months.
It is marketed by Aventis Pharmaceuticals Inc with the brand name Rilutek.
|
 |
Assay:> 98.5%
Apprearnace : Write or light yellow crystal |
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
